Marine Biomedical Research Institution, Guangdong Medical University, Zhanjiang, 524023, People's Republic of China.
Marine Biomedical Research Institution of Guangdong Zhanjiang, Zhanjiang, 524023, People's Republic of China.
Arch Osteoporos. 2024 Apr 22;19(1):30. doi: 10.1007/s11657-024-01386-3.
UNLABELLED: Type 2 diabetic osteoporosis (T2DOP) has received increasing attention from researchers. In this study, a total of 453 publications related to T2DOP from 2013 to 2022 were analyzed using bibliometric and visual analysis to identify the research trends and research hotspots in the field of T2DOP. PURPOSE: The objective of this study was to conduct a comprehensive bibliometric analysis of T2DOP-related publications from 2013 to 2022 to determine global research trends in T2DOP in terms of number of publications, countries/regions, institutions, authors, journals, funding agencies, and keywords. METHODS: All data were collected from the Web of Science Core Collection (WoSCC). All original research publications regarding T2DOP from 2013 to 2022 were retrieved. VOSviewer and Microsoft Office Excel were used to conduct the bibliometric and visual analysis. RESULTS: From 2013 to 2022, 515 relevant publications were published, with a peak in 2022 in the annual number of publications. The countries leading the research were USA and China. Sugimoto was the most influential authors. Capital Medical University and Nanjing Medical University were the most prolific institutions. Osteoporosis International was the most productive journal concerning T2DOP research. National Natural Science Foundation of China was the primary funding source for this research area. "Bone-mineral density", "fracture risk", and "postmenopausal women" were the most high-frequency keywords over the past 10 years. CONCLUSION: This was the first bibliometric study of diabetes mellitus and osteoporosis to exclusively examine type 2 diabetes mellitus. Our findings would provide guidance to understand the research frontiers and hot directions in the near future.
未加标签:2 型糖尿病性骨质疏松症(T2DOP)越来越受到研究人员的关注。本研究采用文献计量学和可视化分析对 2013 年至 2022 年与 T2DOP 相关的 453 篇文献进行分析,以确定 T2DOP 领域的研究趋势和研究热点。
目的:本研究旨在对 2013 年至 2022 年与 T2DOP 相关的文献进行全面的文献计量分析,以确定 T2DOP 的全球研究趋势,包括出版物数量、国家/地区、机构、作者、期刊、资助机构和关键词。
方法:所有数据均来自 Web of Science 核心合集(WoSCC)。检索了 2013 年至 2022 年与 T2DOP 相关的所有原始研究出版物。使用 VOSviewer 和 Microsoft Office Excel 进行文献计量和可视化分析。
结果:从 2013 年至 2022 年,共发表了 515 篇相关文献,其中 2022 年发表的文献数量最多。在研究方面处于领先地位的国家是美国和中国。Sugimoto 是最具影响力的作者。首都医科大学和南京医科大学是发表 T2DOP 研究论文最多的机构。《骨质疏松国际》是发表 T2DOP 研究论文最多的期刊。国家自然科学基金是该研究领域的主要资助来源。“骨矿物质密度”、“骨折风险”和“绝经后妇女”是过去 10 年中出现频率最高的关键词。
结论:这是第一项专门研究 2 型糖尿病的糖尿病和骨质疏松症的文献计量学研究。我们的研究结果将为了解该领域的研究前沿和热点方向提供指导。
Arch Osteoporos. 2024-4-22
Front Endocrinol (Lausanne). 2022
Endocr Metab Immune Disord Drug Targets. 2025
Front Med (Lausanne). 2022-12-8
Endocr Metab Immune Disord Drug Targets. 2024
Hum Vaccin Immunother. 2023-12-31
Hum Vaccin Immunother. 2023-12-31
Heliyon. 2022-9-25
Lancet Diabetes Endocrinol. 2022-3
Diabetes Res Clin Pract. 2022-1
Arch Osteoporos. 2021-8-19